Eye Institute Annual Fall Symposium and Celebration of the Gary W. Abrams Lectureship - BOTH DAYS

Milwaukee, WI US
September 18, 2015 to September 19, 2015

The aim of this program is to provide a comprehensive update on a variety of ophthalmic diseases, placing an emphasis on meeting the current challenges in diagnosis and management. Current challenges involve the use of anti-vascular endothelial growth factor agents in age-related macular degeneration, development of new approaches to treating retinal degenerative diseases, optic neuritis, epiphora, prophylaxis of infection in ophthalmic surgery, and recognition of ocular toxicity.  Clinical implementation of diagnostic imaging modalities such as optical coherence tomography and adaptive optics imaging will also be discussed.

Because of the rapidity with which advancements in ophthalmic imaging technology, surgical instrumentation, and pharmacologic therapies have occurred, rational integration of these modalities into clinical practice has been challenging. To meet this challenge, clinicians must acquire an understanding of both the basic mechanisms underlying such modalities and the means by which they can be applied in a rational fashion to patient care.  In addition, understanding of the underlying disease states must be acquired.  These challenges remain for numerous subspecialty areas in ophthalmology.

Accreditation Statement
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians
 
Designation of Credit Statement
The Medical College of Wisconsin designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
 
Hours of  Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 6.75 hours of participation for continuing education for allied health professionals.
 
 

Please note: a $6.60 processing fee will be assessed for all registrations. 

There is a $50 cancellation fee. 

This course is complimentary for Fellows, Residents and Students; however registration is required; for instructions on how to receive your complimentary registration you must contact Kelli Torosian at 414-955-7875, or ktorosian@mcw.edu  before attempting to register on-line.
 
*Please note:  Google Chrome and Mozilla Firefox are the preferred browsers. 
 
This meeting is supported by Genentech and Regeneron Pharmaceuticals

Target Audience

This educational activity is aimed at practicing ophthalmologists, subspecialty ophthalmologists, optometrists, ophthalmology residents and fellows, medical students, vision scientists, photographers, ophthalmic nurses and technicians.

Learning Objectives

  1. Demonstrate a practical approach to the pharmacotherapy of age-related macular degeneration, ocular infection, and other retinal diseases
  2. Identify and illustrate a rational implementation of optical coherence tomography and other imaging modalities in ophthalmic care
  3. Describe key technological developments in area of vitreoretinal surgery and disease management
Additional information

CME Coordinator Contact Information

Name: 
Kelli Torosian
Phone Number: 
+1 (414) 955-7875
Course summary
Available credit: 
  • 6.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 6.75 Hours of Participation
    Hours of Participation credit.
Course opens: 
06/01/2015
Course expires: 
12/01/2015
Event starts: 
09/18/2015 - 4:00pm
Event ends: 
09/19/2015 - 2:00pm
Cost:
$6.60
Crowne Plaza
10499 Innovation Drive
Milwaukee, WI 53226
United States

Crowne Plaza - Milwaukee West
10499 West Innovation Drive
Wauwatosa, WI 53226
Reservations: 414-475-9500

http://www.crowneplazamilwaukee.com/

Activity Director:
Dennis P. Han, MD
Jack A. & Elaine Klieger Professor of Ophthalmology

Speakers:

All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:  

Name

Company

Role

Gary Abrams, MD, FARVO

Alcon Research Institute

Retrosense Therapeutics, Inc.

Committee

Royalties

H. Culver Boldt, MD

NA

NA

Odette Houghton, MD

NA

NA

Raymond Iezzi, MD, MS

Alimera Sciences

Consultant

Alcon Surgical

Panel Member

Glen Jaffe, MD

Alcon/Novartis

Consultant

Heidelberg

Consultant

Neurotech

Roche

Consultant

Consultant

H. Richard McDonald, MD

NA

NA

Jane Werner, MD

NA

NA

Mitchell Wolf, MD

NA

NA

Edward Barnett, MD

NA

NA

Thomas Connor, Jr., MD

Genentech

Consultant / Speaker

Neda Esmaili, MD

NA

NA

Dennis P. Han, MD

Alcon

Consultant

Flow One Healthcare

Consultant

Judy Kim, MD

Optos

Support

Genentech

Consultant

Allergan

Consultant

Kimberly Stepien, MD

NA

NA

David Weinberg, MD

NA

NA

William Wirostko, MD

NA

NA

Ryan Walsh, MD

NA

NA

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

Available Credit

  • 6.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 6.75 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
06/01/2015
Course expires: 
12/01/2015

Price

Cost:
$6.60
Please login or register to take this course.